Skip to main content
. 2022 Feb 15;13:827544. doi: 10.3389/fneur.2022.827544

Table 4.

Significant different subclasses of lipids of T0 (n = 26) verse control (n = 10) and T2 (n = 26) verse T0 (n = 26).

LipidIon Class Calmz IonFormula RT-(min) T0 vs. control T2 vs. T0
Fold change P-value VIP Fold Change P-value VIP
OAHFA(18:1/34:1)-H OAHFA 785.7392 C52 H97 O4 20.93825 52.16343297 0.036918 2.29603 0.14442499 0.003703 2.80631
OAHFA(18:1/32:1)-H OAHFA 757.7079 C50 H93 O4 19.74312 29.63556255 0.047356 3.88388 0.136615378 0.004611 4.81245
OAHFA(18:1/32:2)-H OAHFA 755.6923 C50 H91 O4 18.67636 36.6853155 0.044402 2.04926 0.150416143 0.005079 2.50278
LPC(18:1)+H LPC 522.3554 C26 H53 O7 N1 P1 2.829591 8.862523744 0.039032 1.58635 0.410042149 0.03062 1.52317
LPC(18:0)+HCOO LPC 568.362 C27 H55 O9 N1 P1 3.790138 3.64099302 0.039047 1.49809 0.494036433 0.034213 1.26986
LPC(18:1)+HCOO LPC 566.3463 C27 H53 O9 N1 P1 2.824801 7.164012181 0.008767 2.12477 0.381895001 0.003515 1.85389
LPC(16:0)+HCOO LPC 540.3307 C25 H51 O9 N1 P1 2.693533 4.427438179 0.035098 3.57942 0.418414154 0.017479 3.33535
LPC(18:2)+H LPC 520.3398 C26 H51 O7 N1 P1 2.251227 2.988598263 0.000856 1.55151 0.586953112 0.005786 1.05027
TG(26:0/16:0/18:1)+Na TG 995.8977 C63 H120 O6 Na1 24.44222 21.32021673 0.020276 1.07358 0.354541857 0.018517 1.12173
TG(18:1/18:2/20:5)+H TG 903.7436 C59 H99 O6 19.71597 5.444758925 0.005544 1.3387 0.489043562 0.006754 1.65819
TG(16:0/18:2/20:5)+H TG 877.728 C57 H97 O6 19.659 5.818026726 0.004927 2.28256 0.470568415 0.004624 1.1926
TG(16:1/18:1/18:2)+NH4 TG 872.7702 C55 H102 O6 N1 19.68893 6.980513631 0.030259 1.53642 0.387629187 0.013507 2.03988
Cer(d17:0/2:0)+H Cer 330.3003 C19 H40 O3 N1 1.913699 3.248423375 2.35E-06 1.85695 0.628695394 0.000317 1.16972
Cer(d18:1/18:0)+HCOO Cer 610.5416 C37 H72 O5 N1 12.32153 0.144934423 0.001796 1.9301 15.03077997 0.026831 3.35324

A number of 13 lipids were significantly increased in T0, whereas they were decreased following IPL treatment. The different lipids were OAHFA(18:1/34:1)-H(C52H97O4), OAHFA(18:1/32:1)-H(C50H93O4), OAHFA(18:1/32:2)-H(C50H91O4), LPC(18:1)+H(C26H53O7N1P1), LPC(18:0)+HCOO(C27H55O9N1P1), LPC(18:1)+HCOO (C27H53O9N1P1), LPC(16:0)+HCOO(C25H51O9N1P1), LPC(18:2)+H(C26H51O7N1 P1), TG(26:0/16:0/18:1)+Na(C63H120O6Na1), TG(18:1/18:2/20:5)+H(C59H99O6), TG(16:0/18:2/20:5)+H(C57H97O6), TG(16:1/18:1/18:2)+NH4 (C55H102O6N1), and Cer(d17:0/2:0)+H(C19 H40 O3 N1).

T0, before treatment; T2, after treatment.